Understanding how to protect insulin-producing cells in diabetes
Biochemical mechanisms of beta cell protection through bromodomain inhibition
This study is looking at how certain proteins can help protect the insulin-producing cells in your pancreas from damage caused by inflammation in Type 1 diabetes, with the hope of finding new ways to keep these cells healthy and improve diabetes management.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Medical College of Wisconsin NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11056740 on NIH RePORTER |
What this research studies
This research investigates the biochemical mechanisms that protect pancreatic beta cells, which are crucial for insulin production, in the context of Type 1 diabetes. It focuses on the role of specific proteins known as BET bromodomains in regulating inflammation that affects these cells. By using inhibitors that target these proteins, the research aims to understand how to improve the function and survival of beta cells, potentially leading to better management of diabetes. Patients may benefit from insights that could lead to new treatments aimed at preserving insulin production.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Type 1 diabetes who are experiencing challenges with insulin production.
Not a fit: Patients with Type 2 diabetes or those without autoimmune diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that protect insulin-producing cells and improve diabetes management.
How similar studies have performed: Previous research has shown that targeting BET proteins can have anti-inflammatory effects and delay diabetes onset in animal models, indicating potential for success in this approach.
Where this research is happening
Milwaukee, United States
- Medical College of Wisconsin — Milwaukee, United States (Active)
Researchers
- Principal investigator: Smith, Brian Christopher — Medical College of Wisconsin
- Study coordinator: Smith, Brian Christopher
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.